| Differential overexpression of SERPINA3 in human prion diseases S Vanni, F Moda, M Zattoni, E Bistaffa, E De Cecco, M Rossi, G Giaccone, ... Scientific reports 7 (1), 15637, 2017 | 61 | 2017 |
| Brain aging: A Ianus‐faced player between health and neurodegeneration S Vanni, A Colini Baldeschi, M Zattoni, G Legname Journal of neuroscience research 98 (2), 299-311, 2020 | 50 | 2020 |
| Myxofibrosarcoma landscape: Diagnostic pitfalls, clinical management and future perspectives S Vanni, A De Vita, L Gurrieri, V Fausti, G Miserocchi, C Spadazzi, ... Therapeutic Advances in Medical Oncology 14, 17588359221093973, 2022 | 47 | 2022 |
| The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells E De Cecco, L Celauro, S Vanni, M Grandolfo, E Bistaffa, F Moda, ... Journal of neurochemistry 155 (5), 577-591, 2020 | 46 | 2020 |
| A rationale for the activity of bone target therapy and tyrosine kinase inhibitor combination in giant cell tumor of bone and desmoplastic fibroma: translational evidences A De Vita, S Vanni, G Miserocchi, V Fausti, F Pieri, C Spadazzi, C Cocchi, ... Biomedicines 10 (2), 372, 2022 | 42 | 2022 |
| The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient‐derived primary culture case series in … A De Vita, F Recine, G Miserocchi, F Pieri, C Spadazzi, C Cocchi, S Vanni, ... Journal of Experimental & Clinical Cancer Research 40 (1), 165, 2021 | 42 | 2021 |
| Serpin signatures in prion and Alzheimer’s diseases M Zattoni, M Mearelli, S Vanni, A Colini Baldeschi, TH Tran, C Ferracin, ... Molecular neurobiology 59 (6), 3778-3799, 2022 | 38 | 2022 |
| Hemoglobin mRNA changes in the frontal cortex of patients with neurodegenerative diseases S Vanni, M Zattoni, F Moda, G Giaccone, F Tagliavini, S Haïk, JP Deslys, ... Frontiers in Neuroscience 12, 8, 2018 | 38 | 2018 |
| Expression pattern of perilipins in human brain during aging and in Alzheimer's disease M Conte, V Medici, D Malagoli, A Chiariello, A Cirrincione, A Davin, ... Neuropathology and Applied Neurobiology 48 (1), e12756, 2022 | 30 | 2022 |
| Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques M Barbisin, S Vanni, AC Schmädicke, J Montag, D Motzkus, L Opitz, ... BMC genomics 15, 1-17, 2014 | 30 | 2014 |
| Precision medicine in head and neck cancers: genomic and preclinical approaches G Miserocchi, C Spadazzi, S Calpona, F De Rosa, A Usai, A De Vita, ... Journal of Personalized Medicine 12 (6), 854, 2022 | 24 | 2022 |
| Deciphering the genomic landscape and pharmacological profile of uncommon entities of adult rhabdomyosarcomas A De Vita, S Vanni, V Fausti, C Cocchi, F Recine, G Miserocchi, C Liverani, ... International Journal of Molecular Sciences 22 (21), 11564, 2021 | 24 | 2021 |
| The emerging role of cancer nanotechnology in the panorama of sarcoma L Mercatali, S Vanni, G Miserocchi, C Liverani, C Spadazzi, C Cocchi, ... Frontiers in bioengineering and biotechnology 10, 953555, 2022 | 23 | 2022 |
| Case report: adult NTRK-rearranged spindle cell neoplasm: early tumor shrinkage in a case with bone and visceral metastases treated with targeted therapy F Recine, A De Vita, V Fausti, F Pieri, A Bongiovanni, E Franchini, ... Frontiers in Oncology 11, 740676, 2022 | 23 | 2022 |
| Systemic inflammatory indices in second-line soft tissue sarcoma patients: focus on lymphocyte/monocyte ratio and trabectedin V Fausti, A De Vita, S Vanni, V Ghini, L Gurrieri, N Riva, R Casadei, ... Cancers 15 (4), 1080, 2023 | 22 | 2023 |
| 3-T magnetic resonance–guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors A Bongiovanni, F Foca, D Oboldi, D Diano, A Bazzocchi, L Fabbri, ... Supportive Care in Cancer 30 (7), 5737-5745, 2022 | 21 | 2022 |
| ALK-negative lung inflammatory myofibroblastic tumor in a young adult: a case report and literature review of molecular alterations SA Debonis, A Bongiovanni, F Pieri, V Fausti, A De Vita, N Riva, L Gurrieri, ... Medicine 100 (20), e25972, 2021 | 14 | 2021 |
| Novel regulators of PrPC expression as potential therapeutic targets in prion diseases A Colini Baldeschi, S Vanni, M Zattoni, G Legname Expert Opinion on Therapeutic Targets 24 (8), 759-776, 2020 | 13 | 2020 |
| Unveiling the genomic basis of chemosensitivity in sarcomas of the extremities: An integrated approach for an unmet clinical need S Vanni, V Fausti, E Fonzi, C Liverani, G Miserocchi, C Spadazzi, ... International Journal of Molecular Sciences 24 (8), 6926, 2023 | 11 | 2023 |
| Innovative non-PrP-targeted drug strategy designed to enhance prion clearance A Colini Baldeschi, M Zattoni, S Vanni, L Nikolic, C Ferracin, G La Sala, ... Journal of medicinal chemistry 65 (13), 8998-9010, 2022 | 10 | 2022 |
